Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12757-12766
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12757
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12757
Ref. | Study design | Types of surgery (n) | Types of colloid | Clinical outcomes of colloid |
Mukhtar et al[77] | RCT | Living donor liver transplantation (40) | 6% HES 130/0.4 vs Alb | No difference in renal outcome |
Rioux et al[78] | Retrospective, propensity score matching | Cardiac surgery (254) | 10% pentastarch 250/0.45 (< 14 mL/kg vs≥ 14 mL/kg) | Dose-dependent renal toxicity |
Hokema et al[79] | Retrospective | Renal transplantation (113) | 6% HES 130/0.4 vs NS or RA | No difference in delayed renal graft function |
Martin et al[64] | Meta-analysis | Various surgical procedures (1230) | 6% HES 130/0.4 vs comparators1 | No differences in renal outcome and length of hospital stay |
Canet et al[80] | Prospective observational, propensity score matching, multicenter | General surgery (2462) | Colloids2vs crystalloids | Increased pulmonary or cardiovascular complications and length of hospital stay |
No difference in mortality | ||||
Van der Linden et al[81] | RCT, double-blind, two-center | Pediatric cardiac surgery (61) | 6% HES 130/0.4 vs Alb | No differences in complications |
Skhirtladze et al[82] | RCT, double-blind | Cardiac surgery (236) | 6% HES 130/0.4 vs Alb vs RL | Both colloids increased blood transfusion, decreased coagulation and increased the creatinine level |
Rasmussen et al[83] | RCT | Cystectomy (33) | 6% HES 130/0.4 vs RL | Increased blood loss and decreased coagulation |
No differences in re-operation and hospital stay | ||||
Kancir et al[84] | RCT | Hip arthroplasty (38) | 6% HES 130/0.4 vs NS | No harmful effect on renal function |
Lindroos et al[85] | RCT | Neurosurgery (30) | 6% HES 130/0.4 vs RA | Decreased coagulation |
No differences in blood loss | ||||
Yates et al[86] | RCT, double-blind | Colorectal surgery (202) | 6% HES 130/0.4 vs RL | No differences in complications |
Gillies et al[65] | Meta-analysis | Non-cardiac surgery (1567) | 6% HES vs comparators1 | No differences in mortality or AKI |
Kashy et al[87] | Retrospective, propensity score matching | Non-cardiac and non-urological surgery (29360) | Colloids3vs crystalloids | Dose-dependent renal toxicity |
Mercier et al[88] | RCT, double-blind, multicenter | Caesarean section (167) | 6% HES 130/0.4 vs RL | Same effects in both mother and neonate |
Hand et al[89] | Retrospective, propensity score matching | Deceased donor liver transplantation (174) | 6% HES 130/0.4 vs Alb | 6% HES increase risk of AKI |
Kancir et al[90] | RCT, double-blind | Radical prostatectomy (36) | 6% HES 130/0.4 vs NS | No difference in renal outcome |
Choi et al[91] | Retrospective | Living donor hepatectomy (1969 ) | 6% HES 130/0.4 vs crystalloids | Postoperative delayed recovery of hepatic function |
- Citation: Choi SS, Kim SH, Kim YK. Fluid management in living donor hepatectomy: Recent issues and perspectives. World J Gastroenterol 2015; 21(45): 12757-12766
- URL: https://www.wjgnet.com/1007-9327/full/v21/i45/12757.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i45.12757